- AU$8.58bn
- AU$8.60bn
- AU$2.35bn
Citi upgrades Australian hearing aid maker Cochlear to 'buy' after recent slump
Australia's Cochlear slumps as HY results, outlook disappoint
Australia's Cochlear faces worst day in 5 years on weak earnings, forecast
Brief: Cochlear Sees FY25 Underlying Net Profit To Be At Lower End Of A$410-430M Guidance Range
Australia's Cochlear slumps as HY results, forecast disappoint
Brief: Cochlear Sees FY25 Underlying Net Profit To Be At Lower End Of A$410-A430M Guidance Range
Brief: Cochlear Posts H1 Net Income Of AUD 205.1 Million
Australia's Cochlear set for weekly drop; UBS hikes PT on FX adjustments
Australia's Cochlear up after Citi upgrades stock on sustained pace of growth
Brief: Cochlear Announces Chief Financial Officer Appointment
Aussie earnings season 'positive surprise' so far, but tide could turn, Macquarie says
Australia's Cochlear slides on weaker-than-expected profit, outlook
Australia's Cochlear tanks on weaker-than-expected profit outlook
Brief: Cochlear Declares Final Dividend A$ 2.10 Per Share
Brief: Cochlear Posts FY Adjusted Net Income A$386.6 Mln
Brief: Cochlear Says FY25 Underlying Net Profit Guidance Range Is A$410-430 Million
Brief: Cochlear Says Stu Sayers, Current Chief Financial Officer, Will Be Appointed President, Asia Pacific & Latin America
Australia, Cochlear support Japan programme for child hearing implants
Aussie healthcare stocks set to log modest gains in first-half 2024